<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="iso-abbrev">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="publisher-id">mt</journal-id><journal-id journal-id-type="coden">aabmcb</journal-id><journal-title-group><journal-title>ACS Applied Bio Materials</journal-title></journal-title-group><issn pub-type="epub">2576-6422</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40304423</article-id><article-id pub-id-type="pmc">PMC12093370</article-id>
<article-id pub-id-type="doi">10.1021/acsabm.5c00263</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Tackling Microbial Contamination in Polydioxanone-Based
Membranes for Regenerative Therapy: Bioengineering an Antibiotic-Loaded
Platform</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Abdo</surname><given-names>Victoria
L.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Shibli</surname><given-names>Jamil A.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff7" ref-type="aff">$</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Costa</surname><given-names>Raphael C.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Rossy Borges</surname><given-names>Maria H.</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Wong</surname><given-names>Ademar</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath6"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6173-7888</contrib-id><name><surname>Sotomayor</surname><given-names>Maria D. P. T.</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Bertolini</surname><given-names>Martinna</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Figueiredo</surname><given-names>Luciene C.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath9"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6391-9917</contrib-id><name><surname>Bar&#x000e3;o</surname><given-names>Valentim A. R.</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath10"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7909-190X</contrib-id><name><surname>Rangel</surname><given-names>Elidiane C.</given-names></name><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath11"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5944-6953</contrib-id><name><surname>Souza</surname><given-names>Joao Gabriel S.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Dental
Research Division, <institution>Universidade Universus
Veritas Guarulhos</institution>, Guarulhos 07023-070, <country>Brazil</country></aff><aff id="aff2"><label>&#x02021;</label>School
of Dentistry, <institution>Alfenas Federal University
(UNIFAL-MG)</institution>, Alfenas 37130-001, <country>Brazil</country></aff><aff id="aff3"><label>&#x000a7;</label>Departamento
of Prosthodontics and Periodontology, Piracicaba Dental School, <institution>Universidade Estadual de Campinas (UNICAMP)</institution>, Piracicaba 13414-903, <country>Brazil</country></aff><aff id="aff4"><label>&#x02225;</label>Institute
of Chemistry, <institution>S&#x000e3;o Paulo State University</institution>, Araraquara 14801-970, <country>Brazil</country></aff><aff id="aff5"><label>&#x022a5;</label>Department
of Periodontics and Preventive Dentistry, <institution>University of Pittsburgh School of Dental Medicine</institution>, Pittsburgh, Pennsylvania 15213, <country>United States</country></aff><aff id="aff6"><label>#</label>Laboratory
of Technological Plasmas, Institute of Science and Technology, <institution>S&#x000e3;o Paulo State University (UNESP)</institution>, Sorocaba 18087-180, <country>Brazil</country></aff><aff id="aff7"><label>$</label>Faculdade
Israelita de Ci&#x000ea;ncias da Sa&#x000fa;de Albert Einstein, <institution>Hospital Israelita Albert Einstein</institution>, S&#x000e3;o Paulo 05653-120, <country>Brazil</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>jgabriel.ssouza@yahoo.com.br</email>.</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>04</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>19</day><month>05</month><year>2025</year></pub-date><volume>8</volume><issue>5</issue><fpage>4119</fpage><lpage>4131</lpage><history><date date-type="received"><day>11</day><month>02</month><year>2025</year></date><date date-type="accepted"><day>20</day><month>04</month><year>2025</year></date><date date-type="rev-recd"><day>18</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_0005" id="ab-tgr1"/></p><p>Barrier membranes
are essential components of tissue regenerative
therapies, acting as physical barriers to protect the healing site.
Although collagen-based membranes are widely used, they degrade enzymatically,
often triggering inflammation and cytotoxicity arising from residual
cross-linking agents. Synthetic polymer-based membranes, such as polydioxanone
(PDO), present customizable properties, predictable degradation rates,
and induce bone formation more effectively. However, both materials
are at risk of exposure to the microbial contamination. To address
this, antibiotics have been loaded onto membranes as drug-delivery
systems, a strategy that has not yet been explored for PDO membranes.
In this study, the oral polymicrobial contamination of PDO-based membranes
was evaluated and compared with collagen membranes and aimed to develop
an amoxicillin-loaded PDO (AMX-PDO) membrane. For this purpose, PDO
membranes with different pore sizes (0.25, 0.50, and 1.00 mm) and
two commercially available collagen membranes were evaluated, using
in vitro and in situ models, in terms of polymicrobial accumulation.
Next, AMX-PDO membranes were developed by glow discharge plasma using
Ar and O<sub>2</sub> gases and an amoxicillin compound. The findings
revealed similar microbial levels for both PDO and collagen-based
membranes, but PDO membranes modulated microbial composition with
reduced (&#x0223c;3&#x02013;5 fold-decrease) levels of specific oral
pathogens. The AMX-PDO membrane maintained similar physical and chemical
properties to those of untreated membranes, but it significantly reduced
polymicrobial accumulation and prevented microbial cells from passing
through them. Thus, they acted as more than passive physical barriers
only, but rather as biologically active barriers. Therefore, amoxicillin
loading on PDO barrier membranes by means of plasma technology seems
to be a promising strategy to prevent local infection during regenerative
therapy.</p></abstract><kwd-group><kwd>membranes</kwd><kwd>guided bone regeneration</kwd><kwd>biofilms</kwd><kwd>bacteria</kwd><kwd>antimicrobial properties</kwd><kwd>amoxicillin</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Conselho Nacional de Desenvolvimento Cient&#x000c3;&#x000ad;fico e Tecnol&#x000c3;&#x000b3;gico</institution><institution-id institution-id-type="doi">10.13039/501100003593</institution-id></institution-wrap></funding-source><award-id>314479/2023-6</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>mt5c00263</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>mt5c00263</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Human body structures
are often affected by tissue damage, resulting
in the loss of architecture, structure, and function, as observed
in bone defects, which pose a significant clinical challenge.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> To address tissue damage, tissue engineering
approaches such as guided bone regeneration (GBR) and guided tissue
regeneration (GTR) are commonly used in dentistry. The aim of these
therapies is to promote healing and restore bone and/or other tissues
by re-establishing the lost tissue architecture and facilitating targeted
regeneration.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Bone loss due to biofilm-related
diseases and tooth loss can compromise the feasibility of oral rehabilitation
and the restoration of oral functions.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Bone regeneration around dental implants with previously contaminated
threads presents significant challenges, primarily due to the difficulty
in achieving effective decontamination of the implant surface.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Contaminated threads harbor biofilms and microbial
deposits that compromise tissue integration and may perpetuate inflammation.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Chemical agents such as chlorhexidine, hydrogen
peroxide, citric acid or even systemic and local antibiotics are applied
to reduce the microbial load further and enhance surface biocompatibility.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup> Despite these efforts, complete decontamination is rarely guaranteed,
thus making the subsequent steps of regeneration even more critical
to the overall success of the procedure. Once the implant surface
has been decontaminated, GBR is used to restore the lost bone and
stabilize the implant.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> During GBR, to
protect graft materials and promote bone regeneration, barrier membranes
are commonly used as passive physical barriers to prevent invasion
of nontarget tissues, such as epithelial or connective tissue, and
microbial cells, while allowing regenerative cells to populate the
defect area.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>In clinical settings,
various types of membranes have been used,
including nonresorbable and resorbable materials, which can be used
alone or in combination with bone substitutes and/or growth factors.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> An effective barrier membrane should facilitate
the transport of blood, nutrients and protein-rich body fluids to
the bone defect area, while maintaining a pore structure that retains
cell products.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> Resorbable membranes have an
important advantage, they do not require a re-entry surgery for membrane
removal.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Among them, collagen-based membranes
are the most commonly used for GBR due to their high biocompatibility,
biodegradability, vascularization, their capacity for inducing cell
migration arising, and low immunogenicity.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> However, collagen membranes often have unfavorable mechanical properties,
such as low rigidity and poor mechanical strength.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Although cross-linking methods have been applied to enhance
the mechanical properties of collagen-based membranes, these techniques
may reduce biocompatibility, due to potential cytotoxic effects arising
from residual cross-linking agents.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> In
recent decades, efforts have been made to produce collagen-based materials
blended with other polymers, such as chitosan, poly-<sc><italic>l</italic></sc>-lactide (PLLA), and hyaluronic acid, to enhance biological
responses, promote cell differentiation, and mimic human tissues.<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> However, these methods can also lead to changes in membrane degradation
rates, reduced swelling behavior, and decreased collagen content,
which is directly dependent on the polymer used in the blend. Furthermore,
clinical evidence is still limited.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> To
improve the mechanical properties of resorbable membranes, synthetic
polymers have been introduced in the market over the past few years,
and have gained prominence in regenerative therapies due to their
customizable mechanical properties, predictable degradation rates,
and structural versatility. Synthetic polymer-based membranes offer
significant advantages for GBR, such as the capacity for good space-maintenance,
a slow resorption rate, adaptability to bone defects, and enhanced
biodegradability, which have led to promising clinical outcomes.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> Among them, the polydioxanone (PDO)-based membranes have demonstrated
higher levels of induction of bone formation and osteogenic differentiation
when compared with collagen-based membranes,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> with the advantage of undergoing hydrolytic degradation, and being
broken down into nontoxic byproducts (primarily glycolic acid).</p><p>Despite their popularity, both type of membranes can often become
exposed to the oral environment, which can lead to microbial contamination,
triggering inflammatory responses, and potentially compromising wound
healing.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> It is noteworthy that the impact
of polymicrobial contamination on these membranes has not been experimentally
tested. Barrier membranes can be colonized by oral pathogens through
exposure to the oral environment or contact with microbial-rich oral
fluids.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> This allows microbial cells and
their metabolites to migrate to the wound healing site, potentially
triggering an inflammatory process that affects bone formation and
even degrading the membrane structure.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> Therefore,
researchers have proposed that a local drug delivery system could
help prevent microbial challenges during the healing process in regenerative
therapies, with different antimicrobial agents being applied to or
incorporated into membrane materials.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> However, the majority of methods have resulted in short-term drug
release which has provided insufficient time for microbial control
postoperatively, or they have often compromised the physical and mechanical
properties, and biocompatibility of the membrane.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> Although systemic antibiotics have been widely used in clinical
practice, they may lead to microbial resistance and reduced effectiveness
at the infection site.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Therefore, loading
antimicrobial agents onto barrier membranes for local delivery has
been widely explored, but has rarely been successful. Amoxicillin,
the most used antibiotic for oral infections, has been loaded onto
membranes, but its antimicrobial effects have typically been tested
on specific microbial species<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> without considering
the polymicrobial nature of oral infections, or its functionalization
on PDO-based membranes.</p><p>Therefore, the aim of this study was
to characterize the polymicrobial
contamination of PDO-based membranes using in vitro and in situ models,
and compare them with collagen-based membranes. An additional aim
was to develop amoxicillin-loaded PDO (AMX-PDO) membranes by using
glow discharge plasma technology, to control microbial accumulation
while simultaneously preserving the biological, physical, and mechanical
properties of the barrier membranes.</p></sec><sec id="sec2"><label>2</label><title>Materials and Methods</title><sec id="sec2.1"><label>2.1</label><title>Materials
and Substrates</title><p>Commercially
available PDO-based membranes (Plenum Guide, Plenum Bioengenharia,
Jundiai, Brazil) with different pore sizes (0.25, 0.50, and 1.00 mm)
were carefully cut into disc shapes (&#x000f8; = 12 mm &#x000d7; 0.5 mm).
These PDO membranes are synthetic materials manufactured by using
the melting electrospinning process. Natural double-sided porcine
collagen-based membranes, commercially available as Bio-Gide (control
1) (Geistlich Pharma AG, Wolhusen, Switzerland) and Straumann Jason
(control 2) (Straumann, Basel, Switzerland), were used as controls.
PDO membranes with different pore sizes were compared with collagen-based
membranes for microbial contamination. The PDO-0.50 membrane, the
size most used in clinical practice, was selected as a substrate for
antibiotic loading treatment. Amoxicillin trihydrate (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S&#x000b7;3H<sub>2</sub>O) (Nova
Qu&#x000ed;mica, Barueri, Brazil) was used for allowing discharge plasma
treatment.</p></sec><sec id="sec2.2"><label>2.2</label><title>In Vitro Polymicrobial
Contamination</title><p>Commercially available PDO membranes with different
pore sizes (PDO-0.25,
PDO-0.50, and PDO-1.00) and collagen-based membrane controls (control
1 and 2) were evaluated in terms of polymicrobial colonization using
a validated in vitro model for implant-related infections.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> For this purpose, a pool of fresh stimulated human saliva from five
volunteers with good systemic and oral health was used as a polymicrobial
inoculum to mimic the human oral microbiome. The inclusion and exclusion
criteria for volunteers were described elsewhere.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> The study was approved by the Local Research and Ethics
Committee (56455222.6.0000.5506) and all participants signed the term
of informed consent. Membrane discs were incubated with the salivary
microbial inoculum in BHI medium (Becton-Dickinson, Sparks, MD, USA)
(10:1 v/v) + sucrose (10:1 v/v) at 37 &#x000b0;C with 5% CO<sub>2</sub> for 24 h and 72 h. Samples were washed 3x with 0.9% NaCl before
analysis to remove detached cells. Experiments were conducted in duplicate.
Biofilms were analyzed in terms of live cell counts, microbial composition
and biofilm structure.</p></sec><sec id="sec2.3"><label>2.3</label><title>Microbial Live Cells and
Biofilm Composition</title><p>After polymicrobial biofilm formation,
membrane discs were immersed
in microcentrifuge tubes containing a 0.9% NaCl solution and vortexed
for 30 s to detach cells. Thus, a serial dilution of a vortexed suspension
was plated on Blood Agar plates to estimate live cell counts by colony-forming
unit (CFU). Live cell counts were expressed on a logarithmic scale
or fold-over. For microbial composition, biofilm suspensions were
analyzed by checkerboard DNA&#x02013;DNA hybridization technique.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> This technique allows evaluation of the presence
and levels (proportions) of 40 bacterial species highly associated
with the progression of oral biofilm-related diseases, such as periodontal
disease and implant-related infections.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup></p></sec><sec id="sec2.4"><label>2.4</label><title>Membrane Morphology and Biofilm Structure</title><p>The morphology
of PDO and collagen-based membranes was analyzed
using scanning electron microscopy (SEM; JEOL JSM-6010LA, Peabody,
MA, USA) by means of electron beams with low accelerating voltages
(3 kV). Biofilms formed on the membranes were also evaluated for their
structure by using SEM imaging. For this purpose, membranes with biofilms
were fixed for 2 h in Karnofsky&#x02019;s fixative solution (containing
2.5% glutaraldehyde, 2% formaldehyde, and 0.1 M sodium phosphate buffer
at pH 7.2). Thus, specimens underwent a series of ethanol washes for
dehydration. Once dried, the specimens were mounted on stubs, sputter-coated
with a thin layer of gold, and subsequently analyzed by SEM operating
at 15 kV.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup></p></sec><sec id="sec2.5"><label>2.5</label><title>In Situ
Biofilm Formation</title><p>To evaluate
the microbial colonization of PDO membranes with different pore sizes,
an in situ study was conducted by exposing the membranes to the oral
cavity of five healthy volunteers to microbial accumulation. In clinical
practice, since barrier membranes are commonly placed over implantable
devices during oral rehabilitation, membrane discs were mounted on
titanium (Ti) discs (&#x003d5;12 mm &#x000d7; 2 mm) made of Ti&#x02013;6Al-4
V powders with a particle size of 25&#x02013;45&#x02009;&#x003bc;m, manufactured
by means of additive manufacturing technology (Plenum&#x02013;Jundiai,
S&#x000e3;o Paulo, Brazil). A previously established in situ model
was used,<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> in which a palatal appliance containing
membrane discs of each pore size (0.25, 0.50, and 1.00) (&#x003d5; =
12 mm &#x000d7; 0.5 mm) were placed over Ti discs. These discs and membranes
fixed in the appliances were protected by plastic mesh to allow biofilm
accumulation. Samples were exposed extraoral 4&#x000d7;/day to a 20%
(v/v) sucrose solution to promote the growth of implant-associated
pathogens, in order to achieve bacterial loads similar to those observed
in clinical trials involving patients with implant-related infections.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref></sup> On the morning of the fourth day, membranes were collected from
volunteers and analyzed for live cell counts. Ti discs not covered
by membranes were used as controls for maximum biofilm formation.
Membranes not used for live cell counts were analyzed using SEM imaging,
similar to the procedures described above.</p></sec><sec id="sec2.6"><label>2.6</label><title>Antibiotic-Loaded
Membrane Development</title><p>The antibiotic treatment was conducted
by using a plasma-enhanced
chemical vapor deposition technique.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> For this purpose,
a PDO membrane with a pore size of 0.50 mm was chosen since it is
widely use in clinical practice and because it qualitatively showed
fewer adhered bacterial cells when compared with the other pore sizes.
The glow discharge system consists of a stainless-steel reactor chamber
with two parallel-plate, horizontal, circular electrodes, a radiofrequency
(RF) generator operating at 13.56 MHz with an output power of up to
300 W, and a vacuum system.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> For the plasma
treatment, PDO-0.50 membrane discs were bound onto the upper electrode
and the amoxicillin powder (1 g) was dispersed on the lower electrode.
Then, the reactor was evacuated to a background pressure of &#x02248;2.0
&#x000d7; 10<sup>&#x02013;2</sup> Torr. Plasma depositions were prepared
from mixtures of 85% Ar and 15% O<sub>2</sub> applied using 13.56
MHz and 150 W in the lower electrode for 15 min. The total pressure
of gases of 4.0 &#x000d7; 10<sup>&#x02013;2</sup> Torr was kept for all
treatments. After 900 s of the process, membrane discs were removed
from the reactor at room temperature. AMX-PDO-treated membranes were
evaluated for their physical, mechanical, biological, and microbiological
properties. Untreated PDO-0.50 membranes were used as controls.</p><sec id="sec2.6.1"><label>2.6.1</label><title>Surface Topography/Morphology of AMX-PDO-Treated
Membranes</title><p>The surface morphology of the treated and control
membranes was analyzed using SEM (JEOL JSM-6010LA, JEOL), and their
chemical composition was evaluated through energy-dispersive spectroscopy
(EDS) with a detector attached to the SEM, operating at beam energies
of 5.0 and 10.0 keV.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup></p></sec><sec id="sec2.6.2"><label>2.6.2</label><title>Molecular Structure</title><p>Fourier transform
infrared spectroscopy (FTIR) was performed using a Jasco FTIR 410
spectrometer (Tokyo, Japan) to analyze the molecular structure of
the AMX-PDO and control membranes. The spectra represented the average
of 128 scans acquired at a resolution of 4 cm<sup>&#x02013;1</sup>.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup></p></sec><sec id="sec2.6.3"><label>2.6.3</label><title>Membrane Surface Roughness</title><p>The
surface roughness of the membranes was measured using topographic
profiles acquired with a profilometer (Dektak D150; Veeco system).
The arithmetic roughness (<italic>R</italic><sub>a</sub>) and total
roughness (<italic>R</italic><sub>t</sub>) were estimated in micrometers
(&#x003bc;m).</p></sec><sec id="sec2.6.4"><label>2.6.4</label><title>Extensional Tensile Resistance</title><p>Tensile tests were conducted using a UXF (Universal Extensional
Fixture)
accessory, where DMA tensile tests were performed. Based on the specified
maximum torque, it was possible to calculate the maximum allowable
total stress. The tensile tests were conducted to determine the linear
elastic region of the material, where the slope of this linear region
on the extensional stress vs strain graph represents Young&#x02019;s
modulus. The higher the Young&#x02019;s modulus, the greater the stress
required to produce a certain deformation. Oscillatory measurements
were performed under a constant prestress overlay. Extensional Viscosity
Test&#x02013;Multidrive: for extensional stress (&#x003c3;), the number
of points was defined by the equipment (264 points), and a logarithmic
ramp profile from 0.01 to 30 s was selected. The extensional strain
rate ranged from 0.1 (1/min) to 1 (1/min). A thermostatic bath was
used at a temperature between 10 and 15 &#x000b0;C. At the end of the
test, the following were estimated: extensional tension, extensional
deformation, and Young&#x02019;s modulus. The AMX-PDO was compared
with that of an untreated control membrane.</p></sec><sec id="sec2.6.5"><label>2.6.5</label><title>AMX-PDO-Treated
Membrane Degradation</title><p>To evaluate the degradability of the
membranes, AMX-PDO and control
membrane discs were incubated in a 0.9% NaCl solution (2 mL) at 37
&#x000b0;C for 30 days. The membrane weights were measured before the
assay and after 30 days to assess weight loss as an indicator of degradability,
in accordance with ISO 10993-13:2010 guidelines.</p></sec><sec id="sec2.6.6"><label>2.6.6</label><title>AMX Drug-Release</title><p>For the drug release
assay, AMX-PDO membranes were placed in tubes containing 0.9% NaCl
solution, and the solutions were collected after 1, 3, and 7 days
to evaluate amoxicillin concentration using high-performance liquid
chromatography with ultraviolet detection (HPLC-UV). The amoxicillin
solution was prepared weighing a mass of 3.65 mg of this compound
and solubilized in 0.1 mol L<sup>&#x02013;1</sup> sodium hydroxide
solution in a 5 mL volumetric flask. HPLC-UV analysis was conducted
on a Shimadzu model 20A liquid chromatograph coupled to an SPD-20A
UV/vis detector, an SIL&#x02013;20A autosampler and a DGU&#x02013;20A5
degasser, controlled by a microcomputer. A C18 column (250 &#x000d7;
4.6 mm, Shim&#x02013;Pack CLC&#x02013;ODS) was used, positioned inside
a Shimadzu CTO&#x02013;10AS oven to maintain a constant temperature.
The total running time for amoxicillin standard solution was 7 min
using mobile phase 10<sup>&#x02013;3</sup> mol L<sup>&#x02013;1</sup> phosphate buffer (pH = 5.0) and acetonitrile in the ratio 95:5,
v/v and &#x003bb; = 229 nm.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Results were
expressed in ppm.</p></sec><sec id="sec2.6.7"><label>2.6.7</label><title>Biological Response&#x02013;Protein
Adsorption</title><p>Since protein adsorption is considered the first
biological response
in the human body,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> AMX-PDO and control
membranes were subjected to protein adsorption assays. A pool of stimulated
human saliva from three volunteers was collected at least 2 h after
eating and brushing their teeth. The saliva pool was centrifuged (10
min at 3800 g) to remove cell debris and contaminants. Membrane discs
were then immersed in 1 mL of saliva in a 24-well plate at 35 &#x000b0;C
for 2 h. Subsequently, the membranes were washed three times with
0.9% NaCl to remove nonadsorbed proteins. The membranes were then
immersed in NaCl solution, vortexed, and sonicated to detach adsorbed
proteins. The supernatant was collected and used for protein quantification
by means of the bicinchoninic acid (BCA) method (BCA Kit; Sigma-Aldrich).<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup></p></sec><sec id="sec2.6.8"><label>2.6.8</label><title>Antimicrobial Evaluation of AMX-PDO-Treated
Membranes</title><p>The antimicrobial effect of AMX-PDO membranes,
compared with nontreated membranes, was evaluated in vitro using the
polymicrobial biofilm model described above (item 2.2). For this purpose,
stimulated human saliva from healthy volunteers was used as the microbial
inoculum. Membranes were incubated with the salivary microbial inoculum
in BHI medium (10:1 v/v) + sucrose (10:1 v/v) at 37 &#x000b0;C, with
5% CO<sub>2</sub>, for 24 h. Assays were conducted in duplicate. Biofilms
were analyzed in terms of live cell counts.</p><p>The antimicrobial
ability of the AMX-PDO membrane developed was also evaluated in situ.
For this purpose, three healthy volunteers used palatal appliances
containing the AMX-PDO and control membranes, which were fixed onto
discs and protected by a plastic mesh to allow polymicrobial biofilm
accumulation on the substrate exposed to the human oral environment.
After 24 h, the membranes were collected to estimate live cell counts
and microbial composition by DNA&#x02013;DNA checkerboard hybridization.
Live cell counts were estimated on both the membranes and the discs
to evaluate whether the AMX-PDO membranes reduced the contamination
of Ti discs compared with nontreated membranes.</p></sec></sec><sec id="sec2.7"><label>2.7</label><title>Statistics</title><p>Prism 10.0 (GraphPad,
Boston, USA) was used for statistical analyses and to generate the
graphs. Multiple group comparisons were performed by one-way analysis
of variance (ANOVA) (comparing the PDO-membranes with collagen-based
membranes). Pair-wise comparisons were made with the Bonferroni <italic>t</italic>-test. A significance level of 5% was adopted.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>PDO-Based Membranes Presented
Similar Microbial
Loads when Compared with Collagen-Based Membranes</title><p>Since previous
evidence has overlooked the microbial contamination of resorbable
membranes, which can affect the clinical outcomes of regenerative
therapy,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> we first compared the polymicrobial
contamination of commercially available collagen-based membranes with
PDO-based membranes of different pore sizes by using in vitro and
in situ models (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). SEM images before biofilm formation showed significant differences
among the PDO membranes and both controls (<italic>p</italic> &#x0003c;
0.05), as expected (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). Collagen-based membranes exhibited a dense structure,
characterized by thick, regularly shaped strips (control 1) or a solid
and dense structure (control 2). In contrast, the PDO membrane displayed
thin strips with irregular orientations but of consistent thickness,
while the strip thickness decreased as the pore size increased. Importantly,
PDO-based membranes in all pore sizes exhibited similar (<italic>p</italic> &#x0003e; 0.05) microbial counts at 24- (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C) and 72- (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D) hours of polymicrobial biofilm formation
compared with collagen-based membranes. This finding was confirmed
by SEM images after 72 h of biofilm formation, which showed microbial
clusters on all membranes, with a predominance of coccoid-shaped microbial
species intertwined within the membrane strips (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Polymicrobial contamination of polydioxanone
(PDO) and collagen-based
membranes. (A) Schematic diagram of the experimental design. PDO membranes
with different pore sizes (0.25, 0.50, 1.00 mm) and commercially available
collagen-based membranes (control 1 and 2) were evaluated for polymicrobial
biofilm formation using in vitro and in situ models. Stimulated human
saliva from healthy volunteers was used as the microbial inoculum
to simulate the oral microbiome. (B) Scanning electron microscopy
(SEM) was used to evaluate and compare membrane morphology (&#x000d7;500
magnification). (C) Colony-forming units (CFUs) representing total
bacterial counts after 24 h of in vitro polymicrobial biofilm formation.
(D) CFUs representing total bacterial counts after 72 h of in vitro
polymicrobial biofilm formation (<italic>n</italic> = 5). (E) SEM
images of membranes after 72 h of in vitro biofilm formation (&#x000d7;1,000
magnification).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_0001" id="gr1" position="float"/></fig><p>Although total bacterial counts
were similar among the tested membranes,
the composition and structure of the membranes, however, modulated
the microbial composition of biofilms (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). When compared with collagen-based membranes,
PDO membranes demonstrated reduced levels of important oral pathogens.
Eighteen bacterial species exhibited levels at least 5&#x000d7; higher
on control 1 (collagen-based) than on at least one of the PDO membrane
pore sizes (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B), including key putative pathogens such as <italic>Porphyromonas
gingivalis</italic> and <italic>Tannerella forsythia</italic>. Furthermore, seven bacterial species showed at least 3&#x000d7; higher
counts on control 2 compared with PDO membranes in at least one of
the pore sizes tested (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>C), including Actinomyces and Prevotella species. Therefore,
although the total live bacterial counts were similar, PDO-based membranes
exhibited reduced levels of bacteria associated with oral infections
when compared with collagen-based membranes. Importantly, among the
PDO membranes with different pore sizes, the microbial composition
was similar, with comparable bacterial levels (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00263/suppl_file/mt5c00263_si_001.pdf">Figure S1</ext-link>&#x02013;microbial composition on the PDO membranes
in different sizes).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Microbial composition of polymicrobial biofilms formed
in vitro
on membrane structures, and in situ evaluation. (A) Levels (log10)
of 40 bacterial species associated with oral infections, evaluated
using DNA&#x02013;DNA checkerboard hybridization. (B) Fold-change (control
1/PDO) of bacterial levels showing at least a 5-fold higher count
for control 1 compared with PDO membranes, with an increase observed
in at least one pore size type of PDO membrane. (C) Fold-change (control
1/PDO) of bacterial levels showing at least a 3-fold higher count
for control 2 compared with PDO membranes, with an increase observed
in at least one pore size type of PDO membrane. (D) Scanning electron
microscopy (SEM) images (&#x000d7;3,000 magnification) of PDO membranes
with different pore sizes after in situ biofilm formation. Membrane
discs placed on titanium discs were inserted into palatal appliances
in the oral cavities of healthy volunteers and worn for 3 days. (E)
Colony-forming units (CFUs) of total bacterial counts after in situ
polymicrobial biofilm formation on PDO membranes. Titanium discs not
covered by membranes were used as controls. Error bars indicate standard
deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_0002" id="gr2" position="float"/></fig><p>When the PDO membranes with different
pore sizes were compared
among them, our in situ model, in which membranes were inserted into
the oral cavities of volunteers, showed similar patterns of biofilm
clusters impregnated into the membranes, as observed in SEM images
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>D), as well
as similar live bacterial counts across all pore sizes (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>E). Thus, the pore size of
PDO membranes does not significantly modulate microbial accumulation.</p></sec><sec id="sec3.2"><label>3.2</label><title>Amoxicillin Loading on PDO Membranes Using
Plasma Technology did not Affect the Physical, Mechanical, or Biological
Properties of the Material</title><p>Glow discharge plasma treatment
was used to load the antibiotic amoxicillin onto PDO-0.50 membranes,
a commonly used pore size for resorbable membranes in GBR<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). As expected, the combination of gases and antibiotics
slightly altered the surface morphology of the membrane mesh. SEM
images revealed globular structures adhered to the membrane strips,
possibly representing antibiotic deposition, and a more irregular
strip morphology compared with the control (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Although the basic chemical composition
of the membranes was not affected, as indicated by EDS analysis (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B), FTIR analysis
showed specific peaks, suggesting the presence of amoxicillin on the
membrane structure, as evidenced by the presence of molecular linkages
of C&#x02013;H (2368 cm<sup>&#x02013;1</sup>), C=O (1750 cm<sup>&#x02013;1</sup>), C&#x02013;H&#x02013;N (3650 cm<sup>&#x02013;1</sup>) and O&#x02013;H (3752 cm<sup>&#x02013;1</sup>) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C). The slight change in the
membrane structure significantly increased (<italic>p</italic> &#x0003c;
0.05) the those of the roughness, as indicated by the <italic>R</italic><sub>a</sub> and <italic>R</italic><sub>t</sub> results, with an
average <italic>R</italic><sub>a</sub> of 4.44 &#x003bc;m (&#x000b1;0.48)
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>D). Biodegradability
is an important outcome for resorbable membranes. The antibiotic loading
on PDO membranes did not alter the degradation (weight loss) of the
AMX-PDO membranes after 30 days of incubation in solution, showing
similar results to those of the control group (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>E). The antibiotic loaded onto the membrane
needs to be released into the environment to act as an antimicrobial
agent to control local infection. The drug-release assay confirmed
that the drug was loaded onto the membrane structure and that 49.8
ppm of AMX was released, equivalent to 49.8 &#x003bc;g/mL, after 24
h (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>F). The
concentration showed an approximately a 2-fold increase to 88.75 ppm
after 3 days and remained stable at 79.5 ppm after 7 days, indicating
that a concentration close to 80 ppm represents the maximum release
of the antibiotic by the treated membrane over time.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Development of antibiotic-loaded
PDO membranes. (A) Schematic diagram
of the experimental design. Amoxicillin-loaded PDO-0.50 membranes
(AMX-PDO) were developed using glow discharge plasma technology. The
membranes developed were evaluated for physical, mechanical, biological,
and microbiological properties. Nontreated PDO-0.50 membranes were
used as controls. (B) Scanning electron microscopy (SEM) images of
AMX-PDO and control membranes, in addition to EDS analysis for chemical
composition. (C) FTIR analysis to determine the molecular structure
of the treatment based on the peaks. (D) Membrane surface roughness
evaluated using a profilometer, estimating average roughness (Ra)
and total roughness (<italic>R</italic><sub>t</sub>) in &#x003bc;m.
(E) Degradation of membranes after immersion in 0.9% NaCl and incubation
for 30 days at 37 &#x000b0;C. Membrane weights were measured before and
after the assay. (F) Amoxicillin release assay evaluated by HPLC and
expressed as ppm. Membranes were immersed in NaCl solution and incubated
for 1, 3, and 7 days, and the supernatant was analyzed to estimate
antibiotic concentration. (G) Tensile resistance measuring extensional
tension resistance, (H) extensional deformation resistance, and (I)
Young&#x02019;s modulus. (J) Human salivary protein adsorption on membranes
after 2 h of incubation, evaluated using the bicinchoninic acid (BCA)
method and expressed as absorbance at 562 nm. *<italic>p</italic> &#x0003c;
0.05, using the Bonferroni <italic>t</italic>-test. Error bars indicate
standard deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_0003" id="gr3" position="float"/></fig><p>One of the main advantages
of synthetic membranes is their good
space-maintenance ability and adaptability to bone defects. Therefore,
resistance to tension and deformation is an important outcome to maintain
after plasma treatments. The AMX-PDO membrane showed no difference
in extensional tension resistance (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>G), extensional deformation resistance (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>H), and Young&#x02019;s
modulus compared with the control nontreated membranes. To confirm
the basic properties of the membrane developed, the biological response
was evaluated. For this purpose, a protein adsorption assay was conducted,
as it is considered the first biological response in the human body,
which mediates subsequent biological processes. The AMX-PDO membrane
showed similar human saliva-adsorbed proteins compared with the control
(<italic>p</italic> &#x0003e; 0.05) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>J).</p></sec><sec id="sec3.3"><label>3.3</label><title>AMX-PDO Membranes Reduced
Microbial Accumulation
and the Passage of Microbial Species through the Membrane Structures,
while also Positively Modulating Biofilm Composition</title><p>AMX-PDO
membranes significantly (<italic>p</italic> &#x0003c; 0.05) reduced in
vitro polymicrobial 24 h biofilm formation on the membrane structure
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A) in comparison
with nontreated membranes, showing a 10-fold (1-log) reduction in
total bacterial counts. Although not statistically significant, a
slight reduction was observed in our in situ model, with lower levels
of bacterial counts on AMX-PDO membranes (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). Importantly, antibiotic loading onto
the membrane structure reduced the passage of microbial species to
the implant surface in the in situ model, as Ti discs placed on AMX-PDO
membranes showed significantly (<italic>p</italic> &#x0003c; 0.05) reduced
bacterial counts when compared with nontreated membranes (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Antimicrobial evaluation
of amoxicillin-loaded (AMX-PDO) membranes
when compared with the control. (A) Colony-forming units (CFUs) of
total bacterial counts after 24 h of in vitro polymicrobial biofilm
formation on PDO membranes. (B) CFUs of total bacterial counts after
24 h of in situ polymicrobial biofilm formation on PDO membranes.
(C) CFUs of total bacteria counts after 24 h of in situ polymicrobial
biofilm formation on titanium discs placed under PDO membranes. (D)
Levels (log10) of 40 bacterial species associated with oral infections
on PDO membranes, evaluated using DNA&#x02013;DNA checkerboard hybridization
after in situ biofilm formation. (E) Levels (log10) of 40 bacterial
species associated with oral infections on titanium discs placed on
PDO membranes, evaluated using DNA&#x02013;DNA checkerboard hybridization
after in situ biofilm formation. *<italic>p</italic> &#x0003c; 0.05, using
the Bonferroni <italic>t</italic>-test. Error bars indicate standard
deviations. Error bars indicate standard deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_0004" id="gr4" position="float"/></fig><p>AMX-PDO membranes led to a significant reduction in five
bacterial
species associated with the progression of peri-implant infections,
compared with control: <italic>Treponema socranskii</italic>, <italic>Streptococcus oralis</italic>, <italic>Fusobacterium nucleatum subsp</italic>. <italic>polymorphum</italic>, <italic>Capnocytophaga sutegana</italic>, and <italic>Prevotella intermedia</italic> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>D). The reduction in microbial accumulation
on AMX-PDO membranes also modulated the contamination of Ti discs
placed on the membranes, with the AMX-PDO group showing a reduction
in five bacterial species: <italic>Actinomyces naeslundii</italic>, <italic>Neisseria mucosa</italic>, <italic>Propionibacterium acnes</italic>, <italic>C. sutegana</italic>, and <italic>P. intermedia</italic> (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>E). Notably, two species were
reduced on the membranes&#x02014;<italic>C. sutegana</italic> and <italic>P. intermedia</italic>&#x02014;were also
reduced on the Ti discs.</p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p>Microbial
contamination of wounds and barrier membranes are clinical
challenges that often lead to treatment failures.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Our findings showed similar microbial counts for both PDO
and collagen-based membranes. However, in terms of microbial composition,
which plays a key role in triggering inflammatory processes, PDO membranes
demonstrated reduced levels of important putative oral pathogens,
when compared with collagen membranes. This could be due to their
protein-rich composition, which serves as a potential source of nutrients
for proteolytic bacteria. Bacteria such as <italic>P. gingivalis</italic> and <italic>F. nucleatum</italic>, are known to thrive
in environments where proteins are present, particularly collagen
and other extracellular matrix components.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Importantly, the pore sizes of PDO membranes did not affect in situ
biofilm formation, showing similar outcomes when the membranes were
inserted into the oral cavity of volunteers. To address microbial
contamination on PDO membranes, we developed an antibiotic-loaded
PDO membrane using low-pressure glow discharge plasma technology,
which is commonly applied to biomedical Ti implants.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The antibiotic-loaded membranes significantly reduced polymicrobial
accumulation on the membranes and prevented microbial cells from passing
through to contaminate implantable devices. Therefore, the AMX-PDO
membranes developed retained the barrier membrane properties expected,
particularly since we used a commercially available membrane, while
introducing a new and important feature: microbial control, which
may help prevent initial infections. Thus, our antibiotic-loaded membranes
function as more than passive physical barriers only. These membranes
actively mitigate microbial colonization and reduce the risk of contamination,
making them a more protective and biologically active barrier. Their
dual role enhances the regenerative environment by not only shielding
the surgical site mechanically but also exerting antimicrobial activity,
which reduces inflammation and infection risks. This biologically
active feature elevates their protective efficacy compared with traditional
membranes, fostering improved outcomes in tissue regeneration.</p><p>Synthetic absorbable polymers have been widely used for manufacturing
barrier membranes, due to their excellent uniformity in production,
favorable physical-mechanical properties, and nontoxicity, as their
hydrolysis generally does not induce immune responses.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> PDO-based membranes have been used for orbital
floor fracture,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> defects in the femoral
head,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> and critical bone defects.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Importantly, PDO polymer has a lower degradation
rate compared with other polymers, being considered a slow to moderately
degrading polymer that loses its mass within 6&#x02013;12 months through
hydrolytic degradation.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Previous in vivo
evidence has compared PDO and collagen-based commercially available
membranes and have shown no difference in terms of the percentage
of connective tissue, newformed bone, and remaining biomaterial.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Moreover, both membranes used in our study (collagen
and PDO) have shown no systemic toxicity and the ability to induce
cell migration, adhesion, spreading, and proliferation.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Thus, both membranes, which are commercially
available at present, have pivotal properties for use during GBR in
clinical practice. However, microbial contamination continues to be
a concern.</p><p>Recently, an in vitro study evaluated the microbial
contamination
of the same PDO membranes as those used in this study, compared with
collagen-based types, and showed reduced microbial loads for PDO.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> Although it was a multispecies biofilm, the
study did, however, use specific microbial species, which did not
represent the entire oral microbiome, in the same way as we tested
it, using human saliva as the microbial inoculum. Here, we found similar
total microbial counts for both collagen membranes and the three PDO
membranes with different pore sizes. However, <italic>P. gingivalis</italic> and <italic>T. forsythia</italic> showed more than
a 5-fold reduction on PDO membranes compared with collagen-based membranes
(control 1). These bacterial species are considered the main contributors
to implant-related infections and periodontal tissue destruction.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> Moreover, <italic>P. gingivalis</italic> has demonstrated significant inflammatory induction during regenerative
therapy using mesenchymal stem cells.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Additionally, collagen-binding proteins are recognized for promoting
microbial adhesion, including that of <italic>P. gingivalis</italic> and <italic>T. forsythia</italic>.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Importantly, in this study, we considered microbial presence
throughout the entire membrane, not on its surface only, as microbial
cells can become trapped within the membrane structure. Further studies
are needed to explore the distribution and dispersion of these microbial
species throughout the membrane structure and to evaluate a broader
range of microbial species.</p><p>To address polymicrobial accumulation,
we developed an amoxicillin-loaded
PDO membrane with the aim of preventing and controlling local infections
during regenerative therapy. Bioengineering technologies have been
widely applied to develop barrier membranes with antimicrobial properties,
as this ability is of utmost importance, with acute infection being
identified as one of the main complications during GBR.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> Although antibiotics have been
one of the main agents loaded onto barrier membranes, mainly using
electrospinning technology, various other antimicrobial agents, such
as silver, zinc, and chlorhexidine, have also been incorporated into
membranes.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> The rationale for using antibiotics
loaded onto membranes is based on their broad-spectrum effects, targeting
both Gram-positive and Gram-negative bacterial species. Moreover,
systemic antibiotics such as metronidazole and amoxicillin have been
the primary choices as adjunctive treatments for periodontal disease
and implant-related infections, and have effectiveness against oral
bacteria species.<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> Although clinical evidence has
shown no additional benefit of systemic antibiotics during GBR, the
use of amoxicillin, a broad-spectrum antibiotic, has demonstrated
some effectiveness in controlling initial inflammation during GTR.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> This antibiotic is highly recognized for its effectiveness against
the oral microbiome, drastically reducing the metabolic activity of
tooth-related biofilms.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> Therefore, since
the prolonged use of antibiotic protocols, including amoxicillin,
leads to an increased risk of antimicrobial resistance<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> and systemic side effects, the development of
local therapies is of utmost importance for clinical practice.</p><p>Importantly, both materials (PDO-based membranes and the amoxicillin
antibiotic) used in this study are commercially available at present
and have been used in dental clinical practice in an isolated form.
The PDO membranes tested in our study are commercially available and
have previously been tested in in vivo models, with no toxicity effects
expected.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Moreover, amoxicillin is an
antibiotic widely used in dental practice. The antibiotic concentration
included in the reactor during plasma treatment (1 g) is the same
concentration as that commonly used daily to treat periodontal infections
in dental practice, which recommends this regimen for 14 days.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Importantly, as shown by the release assay,
approximately 10% of the concentration was incorporated into the membrane
structure. Systemic use of amoxicillin results in a concentration
of 14.05 &#x003bc;g/mL in the gingival crevicular fluid,<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> which has shown effectiveness against oral biofilm-induced
diseases. Here, we achieved a release concentration three times higher
within 24 h, which remains below the toxicity threshold for human
osteoblasts and cell lines.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Moreover,
the protein adsorption level observed for AMX-PDO membranes&#x02014;an
important step mediating subsequent biological responses<sup><xref ref-type="bibr" rid="ref59">59</xref></sup>&#x02014;suggests the maintenance of biocompatibility
properties. However, this aspect requires further exploration, particularly
concerning bone-related cells.</p><p>Glow discharge plasma technology
have been widely used to create
coatings with antimicrobial abilities and improved biological responses
on biomedical devices.<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> Since we used commercially available
PDO membranes, it was important to preserve their physical-mechanical
properties to maintain their established clinical applications. The
plasma treatment did not alter membrane morphology, biodegradability,
or tensile resistance, which are important aspects for GBR therapy.
Although roughness was increased, it is unlikely to affect biological
behavior, given the inherently irregular structure of synthetic barrier
membranes.</p><p>Previous studies, using encapsulated amoxicillin
in poly(D,<sc>l</sc>-lactic acid) (PDLLA) nanofiber membranes for
GTR applied by
the electrospinning technique, showed no changes in the membrane morphology,
60% antibiotic release within the first week, and a reduced inflammatory
response.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> The antimicrobial effect against
two bacterial species: <italic>Streptococcus sanguinis</italic> and <italic>Porphyromonas gingivalis</italic>, was
evaluated and reported.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> However, oral
infections have a polymicrobial profile,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> and the development of new biomaterials needs to address this characteristic.
The functionalization of amoxicillin on PDO membranes has not previously
been reported in the literature. However, PDO polymer has been highlighted
as a promising agent for sustained drug delivery, mainly through copolymerization,
encapsulation of agents, and electrospinning, with the effectiveness
being highly related to the hydrophobicity of the polymer.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup></p><p>Antibiotic resistance is a common concern
relative to the use of
such drugs loaded onto biomaterials. Importantly, the use of amoxicillin
(500 mg) twice a day for 14 days has been the main treatment protocol
for periodontal disease and has been widely used clinically for more
than a decade.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Clinical evidence has
shown that the use of a higher dosage of amoxicillin (1 g, three times
a day) led to a modest and short-lived increase in amoxicillin-resistant
bacteria.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> Moreover, important oral bacteria
are susceptible to the effects of amoxicillin, leading to bacterial
death,<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> and the concentration released
from our membrane is more than five times higher than the minimum
inhibitory concentration previously reported for common periodontal
pathogens.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> Therefore, it is expected
that the antibiotic released here does not lead to antimicrobial resistance,
especially considering that the entire antibiotic content was released
within 3&#x02013;7 days. However, this outcome requires further molecular
evaluation. Another important consideration is the potential for the
antibiotic to induce microbial changes, such as an effect of dysbiosis.
Nevertheless, given the rapid antibiotic release, its concentration,
and the microbial findings showing a reduction in important pathogens,
it is expected that the antibiotic-loaded membranes will promote a
health-associated profile.</p><p>Our newly developed AMX-PDO membranes
were able to reduce approximately
1.3-log of in vitro polymicrobial biofilm. This showed that antibiotic
released was able to control microbial accumulation or lead to bacteriostatic
and/or bactericidal effects. The antimicrobial effect may prevent
initial infections during wound healing, which can be applied to other
mucosal membranes and extra oral sites. One of the main purposes of
barrier membranes is to preserve cellular components at the wound
site and prevent the passage of external agents that affect wound
healing and the regenerative process.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> Therefore,
antimicrobial ability is crucial to prevent the passage of viable
microbial cells, transforming a simply &#x0201c;physical barrier membrane&#x0201d;
into a biologically active membrane. In fact, our in situ findings
showed reduced live microbial counts on the implant surface placed
above the AMX-PDO membrane, demonstrating its effectiveness in reducing
wound contamination. <italic>P. intermedia</italic> and <italic>F. nucleatum</italic> microbial species were significantly
reduced on the AMX-PDO membranes. These bacteria are highly associated
with periodontal diseases and implant-related infections.<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref66">66</xref></sup><italic>P. intermedia</italic> was also significantly
reduced on the implant surface, demonstrating the effectiveness of
AMX-PDO membranes in reducing the risk of infections. Amoxicillin
demonstrates an effective antimicrobial action against a wide range
of Gram-positive bacteria and some Gram-negative species, acting by
binding to penicillin-binding proteins, which results in cell wall
lysis and bacterial cell destruction.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> Therefore, the functionalization of amoxicillin on PDO membranes
effectively reduced microbial loads and modulated biofilm composition.
Further studies using high-throughput techniques are needed to evaluate
the antimicrobial effect across a wide range of microbial species
and at different stages of microbial contamination to fully understand
its effectiveness.</p><p>In addition to its potential applications
in oral tissue regeneration,
the AMX-PDO membrane, with its antibiotic-loaded and functionalized
properties, could prove valuable in a variety of other medical fields.
Its ability to reduce microbial biofilm and prevent infection makes
it ideal for use in other mucosal sites, such as the nasal passages,
gastrointestinal tract, or any other mucosal sites, where bacterial
contamination can impede healing and lead to further complications.
Furthermore, the membrane could be beneficial in treating chronic
skin ulcers, including diabetic foot ulcers and pressure sores, where
infection control and wound healing are critical. By offering a personalized,
electrospinning fabrication, the AMX-PDO membrane can be tailored
to the specific size and shape of the wound site, improving its fit
and effectiveness in treating complex or irregularly shaped wounds.
The antimicrobial properties of the membrane also offer a significant
advantage in preventing infection at these sites, reducing the need
for systemic antibiotics and promoting more localized, controlled
healing. Beyond wound care, this type of functionalized membrane could
be used in surgical procedures that require tissue regeneration, such
as soft tissue grafting or implant surgeries, where preventing microbial
contamination is essential for long-term success.<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> The adaptability of the AMX-PDO membrane, combined with
its biologically active properties, holds great promise for a broad
range of medical applications, from dermatology to implantology and
other fields.</p></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p>Thus,
PDO-based membranes exhibited a similar load of polymicrobial
accumulation to those of commercially available collagen-based membranes.
However, PDO membranes were able to modulate oral microbial communities,
significantly reducing the levels of proteolytic oral pathogens associated
with biofilm-induced diseases. To control microbial accumulation,
amoxicillin was successfully loaded onto the PDO membrane structure
by plasma treatment, without altering the physical or mechanical properties
of the membrane. The antibiotic released from the treated-membrane
effectively reduced polymicrobial accumulation, preventing viable
microbial cells from passing through the membrane and contaminating
implant devices placed above it. This antimicrobial effect resulted
in a decrease in both total bacterial levels and specific microbial
species, including those related to periodontal disease and implant-related
infections.</p></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsabm.5c00263?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsabm.5c00263</ext-link>.<list id="silist" list-type="simple"><list-item><p>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00263/suppl_file/mt5c00263_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00263_si_001.pdf"><caption><p>mt5c00263_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes4"><title>Author Contributions</title><p>Conceptualization:
VLA, JGSS; Data curation and. formal analysis: VLA, LCF, RCC, AW,
JGSS; Investigativo: VLA, JAS, MDPTS, MHRB, JGSS; Writing: VLA, MDPTS,
LCF, MHRB, JGSS; Review and. editing: JGSS, JAS, RCC, MB, VARB, ECR.
All authors have given approval to the final version of the manuscript.</p></notes><notes notes-type="funding-statement" id="notes2"><p>The Article Processing
Charge for the publication of this research was funded by the Coordenacao
de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (ROR
identifier: 00x0ma614). Coordenacao de Aperfeicoamento Pessoal de
Nivel Superior (CAPES), Brazil (Code: 001).</p></notes><notes notes-type="COI-statement" id="notes3"><p>The authors
declare the following competing financial interest(s): Jamil Shibli
ownership of stocks or shares at Plenum Bioengenharia.</p></notes><ack><title>Acknowledgments</title><p>The authors thank
Plenum Bioengenharia for supplying
the PDO membranes.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Persidis</surname><given-names>A.</given-names></name>
<article-title>Tissue engineering</article-title>. <source>Nat. Biotechnol.</source>
<year>1999</year>, <volume>17</volume> (<issue>5</issue>), <fpage>508</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1038/8700</pub-id>.<pub-id pub-id-type="pmid">10331816</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Guo</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Du</surname><given-names>J.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>
<article-title>Challenges and Tissue Engineering Strategies of Periodontal-Guided
Tissue Regeneration</article-title>. <source>Methods</source>
<year>2022</year>, <volume>28</volume>, <fpage>405</fpage>&#x02013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2022.0106</pub-id>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Elgali</surname><given-names>I.</given-names></name>; <name><surname>Omar</surname><given-names>O.</given-names></name>; <name><surname>Dahlin</surname><given-names>C.</given-names></name>; <name><surname>Thomsen</surname><given-names>P.</given-names></name>
<article-title>Guided bone
regeneration:
materials and biological mechanisms revisited</article-title>. <source>Eur. J. Oral Sci.</source>
<year>2017</year>, <volume>125</volume> (<issue>5</issue>), <fpage>315</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1111/eos.12364</pub-id>.<pub-id pub-id-type="pmid">28833567</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Noelken</surname><given-names>R.</given-names></name>; <name><surname>Al-Nawas</surname><given-names>B.</given-names></name>
<article-title>Bone regeneration as treatment of peri-implant disease:
A narrative review</article-title>. <source>Clin. Implant Dent. Relat.
Res.</source>
<year>2023</year>, <volume>25</volume> (<issue>4</issue>), <fpage>696</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1111/cid.13209</pub-id>.<pub-id pub-id-type="pmid">37199027</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Bertolini</surname><given-names>M. M.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Nagay</surname><given-names>B. E.</given-names></name>; <name><surname>Dongari-Bagtzoglou</surname><given-names>A.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Targeting implant-associated infections: titanium surface
loaded with antimicrobial</article-title>. <source>iScience</source>
<year>2021</year>, <volume>24</volume> (<issue>1</issue>), <fpage>102008</fpage><pub-id pub-id-type="doi">10.1016/j.isci.2020.102008</pub-id>.<pub-id pub-id-type="pmid">33490916</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Lima</surname><given-names>C. V.</given-names></name>; <name><surname>Costa
Oliveira</surname><given-names>B. E.</given-names></name>; <name><surname>Ricomini-Filho</surname><given-names>A. P.</given-names></name>; <name><surname>Faveri</surname><given-names>M.</given-names></name>; <name><surname>Sukotjo</surname><given-names>C.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Del Bel
Cury</surname><given-names>A. A.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Dose-response effect of chlorhexidine
on a multispecies oral biofilm formed on pure titanium and on a titanium-zirconium
alloy</article-title>. <source>Biofouling</source>
<year>2018</year>, <volume>34</volume> (<issue>10</issue>), <fpage>1175</fpage>&#x02013;<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2018.1557151</pub-id>.<pub-id pub-id-type="pmid">30744421</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Buser</surname><given-names>D.</given-names></name>; <name><surname>Urban</surname><given-names>I.</given-names></name>; <name><surname>Monje</surname><given-names>A.</given-names></name>; <name><surname>Kunrath</surname><given-names>M. F.</given-names></name>; <name><surname>Dahlin</surname><given-names>C.</given-names></name>
<article-title>Guided bone
regeneration in implant dentistry: Basic principle, progress over
35 years, and recent research activities</article-title>. <source>Periodontol</source>
<year>2023</year>, <volume>93</volume> (<issue>1</issue>), <fpage>9</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12539</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Aprile</surname><given-names>P.</given-names></name>; <name><surname>Letourneur</surname><given-names>D.</given-names></name>; <name><surname>Simon-Yarza</surname><given-names>T.</given-names></name>
<article-title>Membranes for Guided Bone Regeneration:
A Road from Bench to Bedside</article-title>. <source>Adv. Healthc Mater.</source>
<year>2020</year>, <volume>9</volume> (<issue>19</issue>), <elocation-id>e2000707</elocation-id><pub-id pub-id-type="doi">10.1002/adhm.202000707</pub-id>.<pub-id pub-id-type="pmid">32864879</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Bottino</surname><given-names>M. C.</given-names></name>; <name><surname>Thomas</surname><given-names>V.</given-names></name>; <name><surname>Schmidt</surname><given-names>G.</given-names></name>; <name><surname>Vohra</surname><given-names>Y. K.</given-names></name>; <name><surname>Chu</surname><given-names>T. M.</given-names></name>; <name><surname>Kowolik</surname><given-names>M. J.</given-names></name>; <name><surname>Janowski</surname><given-names>G. M.</given-names></name>
<article-title>Recent
advances in the development
of GTR/GBR membranes for periodontal regeneration--a materials perspective</article-title>. <source>Dent. Mater.</source>
<year>2012</year>, <volume>28</volume> (<issue>7</issue>), <fpage>703</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2012.04.022</pub-id>.<pub-id pub-id-type="pmid">22592164</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Liu</surname><given-names>K.</given-names></name>; <name><surname>Liao</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Liao</surname><given-names>Y.</given-names></name>; <name><surname>Fu</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Qu</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Yang</surname><given-names>C.</given-names></name>; <name><surname>Ni</surname><given-names>S.</given-names></name>; <name><surname>Zheng</surname><given-names>J.</given-names></name>; <name><surname>Tao</surname><given-names>T. H.</given-names></name>; <name><surname>Zou</surname><given-names>D.</given-names></name>
<article-title>Harmonizing Thickness
and Permeability
in Bone Tissue Engineering: A Novel Silk Fibroin Membrane Inspired
by Spider Silk Dynamics</article-title>. <source>Adv. Mater.</source>
<year>2024</year>, <volume>36</volume> (<issue>13</issue>), <elocation-id>e2310697</elocation-id><pub-id pub-id-type="doi">10.1002/adma.202310697</pub-id>.<pub-id pub-id-type="pmid">38102951</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Cortellini</surname><given-names>P.</given-names></name>; <name><surname>Tonetti</surname><given-names>M. S.</given-names></name>
<article-title>Clinical concepts
for regenerative therapy in intrabony
defects</article-title>. <source>Periodontol 2000</source>
<year>2015</year>, <volume>68</volume> (<issue>1</issue>), <fpage>282</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12048</pub-id>.<pub-id pub-id-type="pmid">25867990</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Allan</surname><given-names>B.</given-names></name>; <name><surname>Ruan</surname><given-names>R.</given-names></name>; <name><surname>Landao-Bassonga</surname><given-names>E.</given-names></name>; <name><surname>Gillman</surname><given-names>N.</given-names></name>; <name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Gao</surname><given-names>J.</given-names></name>; <name><surname>Ruan</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Lee</surname><given-names>C.</given-names></name>; <name><surname>Goonewardene</surname><given-names>M.</given-names></name>; <name><surname>Zheng</surname><given-names>M.</given-names></name>
<article-title>Collagen Membrane for Guided Bone Regeneration in Dental and Orthopedic
Applications</article-title>. <source>Tissue Eng. Part A</source>
<year>2021</year>, <volume>27</volume> (<issue>5&#x02013;6</issue>), <fpage>372</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2020.0140</pub-id>.<pub-id pub-id-type="pmid">32741266</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Kerns</surname><given-names>D. G.</given-names></name>
<article-title>Mechanisms of guided
bone regeneration: a review</article-title>. <source>Open Dent J.</source>
<year>2014</year>, <volume>8</volume>, <fpage>56</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.2174/1874210601408010056</pub-id>.<pub-id pub-id-type="pmid">24894890</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Becker</surname><given-names>J.</given-names></name>; <name><surname>Al-Nawas</surname><given-names>B.</given-names></name>; <name><surname>Klein</surname><given-names>M. O.</given-names></name>; <name><surname>Schliephake</surname><given-names>H.</given-names></name>; <name><surname>Terheyden</surname><given-names>H.</given-names></name>; <name><surname>Schwarz</surname><given-names>F.</given-names></name>
<article-title>Use of a new cross-linked
collagen
membrane for the treatment of dehiscence-type defects at titanium
implants: a prospective, randomized-controlled double-blinded clinical
multicenter study</article-title>. <source>Clin. Oral Implants Res.</source>
<year>2009</year>, <volume>20</volume> (<issue>7</issue>), <fpage>742</fpage>&#x02013;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0501.2008.01689.x</pub-id>.<pub-id pub-id-type="pmid">19302393</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Gon&#x000e7;alves</surname><given-names>F.</given-names></name>; <name><surname>Bentini</surname><given-names>R.</given-names></name>; <name><surname>Burrows</surname><given-names>M. C.</given-names></name>; <name><surname>Carreira</surname><given-names>A. C. O.</given-names></name>; <name><surname>Kossugue</surname><given-names>P. M.</given-names></name>; <name><surname>Sogayar</surname><given-names>M. C.</given-names></name>; <name><surname>Catalani</surname><given-names>L. H.</given-names></name>
<article-title>Hybrid
Membranes of PLLA/Collagen
for Bone Tissue Engineering: A Comparative Study of Scaffold Production
Techniques for Optimal Mechanical Properties and Osteoinduction Ability</article-title>. <source>Materials</source>
<year>2015</year>, <volume>8</volume> (<issue>2</issue>), <fpage>408</fpage>&#x02013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.3390/ma8020408</pub-id>.<pub-id pub-id-type="pmid">28787946</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Sionkowska</surname><given-names>A.</given-names></name>
<article-title>Collagen blended
with natural polymers: Recent advances and trends</article-title>. <source>Prog. Polym. Sci.</source>
<year>2021</year>, <volume>122</volume>, <fpage>101452</fpage><pub-id pub-id-type="doi">10.1016/j.progpolymsci.2021.101452</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Luo</surname><given-names>D.</given-names></name>; <name><surname>Yao</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>R.</given-names></name>; <name><surname>Zhao</surname><given-names>R.</given-names></name>; <name><surname>Iqbal</surname><given-names>M. Z.</given-names></name>; <name><surname>Mushtaq</surname><given-names>A.</given-names></name>; <name><surname>Lee</surname><given-names>I. S.</given-names></name>; <name><surname>Kong</surname><given-names>X.</given-names></name>
<article-title>Silk Fibroin/Collagen Blended Membrane
Fabricated via a Green Papermaking Method for Potential Guided Bone
Regeneration Application: In Vitro and In Vivo Evaluation</article-title>. <source>ACS Biomater. Sci. Eng.</source>
<year>2021</year>, <volume>7</volume> (<issue>12</issue>), <fpage>5788</fpage>&#x02013;<lpage>5797</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.1c01060</pub-id>.<pub-id pub-id-type="pmid">34724784</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>Z.</given-names></name>; <name><surname>Lai</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>P.</given-names></name>; <name><surname>Liao</surname><given-names>L.</given-names></name>; <name><surname>Wei</surname><given-names>J.</given-names></name>
<article-title>Biodegradable Polymer
Membranes Applied
in Guided Bone/Tissue Regeneration: A Review</article-title>. <source>Polymers</source>
<year>2016</year>, <volume>8</volume> (<issue>4</issue>), <fpage>115</fpage><pub-id pub-id-type="doi">10.3390/polym8040115</pub-id>.<pub-id pub-id-type="pmid">30979206</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Santana</surname><given-names>R.</given-names></name>; <name><surname>Gyurko</surname><given-names>R.</given-names></name>; <name><surname>Kanasi</surname><given-names>E.</given-names></name>; <name><surname>Xu</surname><given-names>W. P.</given-names></name>; <name><surname>Dibart</surname><given-names>S.</given-names></name>
<article-title>Synthetic
polymeric barrier membrane associated with blood coagulum, human allograft,
or bovine bone substitute for ridge preservation: a randomized, controlled,
clinical and histological trial</article-title>. <source>Int. J. Oral
Maxillofac Surg</source>
<year>2019</year>, <volume>48</volume> (<issue>5</issue>), <fpage>675</fpage>&#x02013;<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijom.2018.02.012</pub-id>.<pub-id pub-id-type="pmid">31014520</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Saska</surname><given-names>S.</given-names></name>; <name><surname>Pilatti</surname><given-names>L.</given-names></name>; <name><surname>Silva</surname><given-names>E. S. S.</given-names></name>; <name><surname>Nagasawa</surname><given-names>M. A.</given-names></name>; <name><surname>C&#x000e2;mara</surname><given-names>D.</given-names></name>; <name><surname>Lizier</surname><given-names>N.</given-names></name>; <name><surname>Finger</surname><given-names>E.</given-names></name>; <name><surname>Dyszkiewicz
Konwi&#x00144;ska</surname><given-names>M.</given-names></name>; <name><surname>Kempisty</surname><given-names>B.</given-names></name>; <name><surname>Tunchel</surname><given-names>S.</given-names></name>; <name><surname>Blay</surname><given-names>A.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>
<article-title>Polydioxanone-Based
Membranes for Bone Regeneration</article-title>. <source>Polymers</source>
<year>2021</year>, <volume>13</volume> (<issue>11</issue>), <fpage>1685</fpage><pub-id pub-id-type="doi">10.3390/polym13111685</pub-id>.<pub-id pub-id-type="pmid">34064251</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Abdo</surname><given-names>V. L.</given-names></name>; <name><surname>Suarez</surname><given-names>L. J.</given-names></name>; <name><surname>de Paula</surname><given-names>L. G.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Shibli</surname><given-names>J.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>
<article-title>Underestimated microbial infection
of resorbable membranes
on guided regeneration</article-title>. <source>Colloids Surf. B Biointerfaces</source>
<year>2023</year>, <volume>226</volume>, <fpage>113318</fpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2023.113318</pub-id>.<pub-id pub-id-type="pmid">37075523</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Mizraji</surname><given-names>G.</given-names></name>; <name><surname>Davidzohn</surname><given-names>A.</given-names></name>; <name><surname>Gursoy</surname><given-names>M.</given-names></name>; <name><surname>Gursoy</surname><given-names>U.</given-names></name>; <name><surname>Shapira</surname><given-names>L.</given-names></name>; <name><surname>Wilensky</surname><given-names>A.</given-names></name>
<article-title>Membrane barriers
for guided bone regeneration: An
overview of available biomaterials</article-title>. <source>Periodontol</source>
<year>2023</year>, <volume>93</volume> (<issue>1</issue>), <fpage>56</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12502</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Toledano-Osorio</surname><given-names>M.</given-names></name>; <name><surname>Manzano-Moreno</surname><given-names>F. J.</given-names></name>; <name><surname>Toledano</surname><given-names>M.</given-names></name>; <name><surname>Osorio</surname><given-names>R.</given-names></name>; <name><surname>Medina-Castillo</surname><given-names>A. L.</given-names></name>; <name><surname>Costela-Ruiz</surname><given-names>V. J.</given-names></name>; <name><surname>Ruiz</surname><given-names>C.</given-names></name>
<article-title>Doxycycline-doped membranes induced
osteogenic gene expression on osteoblastic cells</article-title>. <source>J. Dent.</source>
<year>2021</year>, <volume>109</volume>, <fpage>103676</fpage><pub-id pub-id-type="doi">10.1016/j.jdent.2021.103676</pub-id>.<pub-id pub-id-type="pmid">33891990</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Kurti&#x0015f;</surname><given-names>B.</given-names></name>; <name><surname>Unsal</surname><given-names>B.</given-names></name>; <name><surname>Cetiner</surname><given-names>D.</given-names></name>; <name><surname>G&#x000fc;ltekin</surname><given-names>E.</given-names></name>; <name><surname>Ozcan</surname><given-names>G.</given-names></name>; <name><surname>Celebi</surname><given-names>N.</given-names></name>; <name><surname>Ocak</surname><given-names>O.</given-names></name>
<article-title>Effect of
polylactide/glycolide
(PLGA) membranes loaded with metronidazole on periodontal regeneration
following guided tissue regeneration in dogs</article-title>. <source>J. Periodontol</source>
<year>2002</year>, <volume>73</volume> (<issue>7</issue>), <fpage>694</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2002.73.7.694</pub-id>.<pub-id pub-id-type="pmid">12146527</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Furtos</surname><given-names>G.</given-names></name>; <name><surname>Rivero</surname><given-names>G.</given-names></name>; <name><surname>Rapuntean</surname><given-names>S.</given-names></name>; <name><surname>Abraham</surname><given-names>G. A.</given-names></name>
<article-title>Amoxicillin-loaded
electrospun nanocomposite membranes for dental applications</article-title>. <source>J. Biomed Mater. Res. B Appl. Biomater</source>
<year>2017</year>, <volume>105</volume> (<issue>5</issue>), <fpage>966</fpage>&#x02013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.33629</pub-id>.<pub-id pub-id-type="pmid">26856526</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Ho</surname><given-names>M. H.</given-names></name>; <name><surname>Claudia</surname><given-names>J. C.</given-names></name>; <name><surname>Tai</surname><given-names>W. C.</given-names></name>; <name><surname>Huang</surname><given-names>K. Y.</given-names></name>; <name><surname>Lai</surname><given-names>C. H.</given-names></name>; <name><surname>Chang</surname><given-names>C. H.</given-names></name>; <name><surname>Chang</surname><given-names>Y. C.</given-names></name>; <name><surname>Wu</surname><given-names>Y. C.</given-names></name>; <name><surname>Kuo</surname><given-names>M. Y.</given-names></name>; <name><surname>Chang</surname><given-names>P. C.</given-names></name>
<article-title>The treatment response of barrier
membrane with amoxicillin-loaded
nanofibers in experimental periodontitis</article-title>. <source>J.
Periodontol</source>
<year>2021</year>, <volume>92</volume> (<issue>6</issue>), <fpage>886</fpage>&#x02013;<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1002/jper.20-0256</pub-id>.<pub-id pub-id-type="pmid">32996124</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Dini</surname><given-names>C.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Klein</surname><given-names>M. I.</given-names></name>; <name><surname>de Avila</surname><given-names>&#x000c9;. D.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>In-vitro
polymicrobial oral biofilm model represents clinical microbial profile
and disease progression during implant-related infections</article-title>. <source>J. Appl. Microbiol.</source>
<year>2023</year>, <volume>134</volume> (<issue>11</issue>), <fpage>lxad265</fpage><pub-id pub-id-type="doi">10.1093/jambio/lxad265</pub-id>.<pub-id pub-id-type="pmid">37951291</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Takeda</surname><given-names>T. T. S.</given-names></name>; <name><surname>Dini</surname><given-names>C.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Ferreira</surname><given-names>R. C.</given-names></name>; <name><surname>Pereira</surname><given-names>G.</given-names></name>; <name><surname>Sacramento</surname><given-names>C. M.</given-names></name>; <name><surname>Ruiz</surname><given-names>K. G. S.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Bar&#x00061;&#x00305;o</surname><given-names>V. A. R.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>
<article-title>Efficacy of a novel three-step decontamination protocol
for titanium-based dental implants: An in vitro and in vivo study</article-title>. <source>Clin. Oral Implants Res.</source>
<year>2024</year>, <volume>35</volume> (<issue>3</issue>), <fpage>268</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1111/clr.14224</pub-id>.<pub-id pub-id-type="pmid">38131526</pub-id>
</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Cury</surname><given-names>J. A.</given-names></name>; <name><surname>Ricomini Filho</surname><given-names>A. P.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Faveri</surname><given-names>M.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Effect of sucrose on biofilm formed in situ on titanium
material</article-title>. <source>J. Periodontol</source>
<year>2019</year>, <volume>90</volume> (<issue>2</issue>), <fpage>141</fpage>&#x02013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1002/JPER.18-0219</pub-id>.<pub-id pub-id-type="pmid">30070706</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Socransky</surname><given-names>S. S.</given-names></name>; <name><surname>Smith</surname><given-names>C.</given-names></name>; <name><surname>Martin</surname><given-names>L.</given-names></name>; <name><surname>Paster</surname><given-names>B. J.</given-names></name>; <name><surname>Dewhirst</surname><given-names>F. E.</given-names></name>; <name><surname>Levin</surname><given-names>A. E.</given-names></name>
<article-title>"Checkerboard&#x02033; DNA-DNA
hybridization</article-title>. <source>Biotechniques</source>
<year>1994</year>, <volume>17</volume> (<issue>4</issue>), <fpage>788</fpage>&#x02013;<lpage>792</lpage>.<pub-id pub-id-type="pmid">7833043</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Cordeiro</surname><given-names>J. M.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>de Avila</surname><given-names>E. D.</given-names></name>; <name><surname>Landers</surname><given-names>R.</given-names></name>; <name><surname>Rangel</surname><given-names>E. C.</given-names></name>; <name><surname>Fortulan</surname><given-names>C. A.</given-names></name>; <name><surname>Retamal-Valdes</surname><given-names>B.</given-names></name>; <name><surname>da Cruz</surname><given-names>N. C.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Synthesis
of bioactive glass-based coating by plasma electrolytic oxidation:
Untangling a new deposition pathway toward titanium implant surfaces</article-title>. <source>J. Colloid Interface Sci.</source>
<year>2020</year>, <volume>579</volume>, <fpage>680</fpage>&#x02013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2020.06.102</pub-id>.<pub-id pub-id-type="pmid">32652323</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Melo</surname><given-names>L.</given-names></name>; <name><surname>Ferrari</surname><given-names>D. S.</given-names></name>; <name><surname>Figueiredo</surname><given-names>L. C.</given-names></name>; <name><surname>Faveri</surname><given-names>M.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>
<article-title>Composition of supra- and subgingival
biofilm of subjects with healthy and diseased implants</article-title>. <source>Clin. Oral Implants Res.</source>
<year>2008</year>, <volume>19</volume> (<issue>10</issue>), <fpage>975</fpage>&#x02013;<lpage>982</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0501.2008.01566.x</pub-id>.<pub-id pub-id-type="pmid">18828812</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Rangel</surname><given-names>E. C.</given-names></name>; <name><surname>Santos</surname><given-names>N. M.</given-names></name>; <name><surname>Bortoleto</surname><given-names>J. R. R.</given-names></name>; <name><surname>Durrant</surname><given-names>S. F.</given-names></name>; <name><surname>Schreiner</surname><given-names>W. H.</given-names></name>; <name><surname>Honda</surname><given-names>R. Y.</given-names></name>; <name><surname>Rangel</surname><given-names>R. C. C.</given-names></name>; <name><surname>Cruz</surname><given-names>N. C.</given-names></name>
<article-title>Treatment of PVC
using an alternative low energy ion bombardment procedure</article-title>. <source>Appl. Surf. Sci.</source>
<year>2011</year>, <volume>258</volume>, <fpage>1854</fpage>&#x02013;<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2011.10.061</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Cordeiro</surname><given-names>J. M.</given-names></name>; <name><surname>Nagay</surname><given-names>B. E.</given-names></name>; <name><surname>de Almeida</surname><given-names>A. B.</given-names></name>; <name><surname>Retamal-Valdes</surname><given-names>B.</given-names></name>; <name><surname>Nociti</surname><given-names>F. H.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Rangel</surname><given-names>E. C.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Targeting Pathogenic Biofilms: Newly
Developed Superhydrophobic Coating Favors a Host-Compatible Microbial
Profile on the Titanium Surface</article-title>. <source>ACS Appl. Mater.
Interfaces</source>
<year>2020</year>, <volume>12</volume> (<issue>9</issue>), <fpage>10118</fpage>&#x02013;<lpage>10129</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b22741</pub-id>.<pub-id pub-id-type="pmid">32049483</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Neto</surname><given-names>A. M. O.</given-names></name>; <name><surname>Schreiner</surname><given-names>W. H.</given-names></name>; <name><surname>Justo</surname><given-names>J. F.</given-names></name>; <name><surname>Oliveira</surname><given-names>A. M.</given-names></name>; <name><surname>Rangel</surname><given-names>E. C.</given-names></name>; <name><surname>Durrant</surname><given-names>S. F.</given-names></name>
<article-title>Characterization of amorphous carbon films by PECVD
and plasma ion implantation: The role of fluorine and sulfur doping</article-title>. <source>Mater. Chem. Phys.</source>
<year>2019</year>, <volume>227</volume>, <fpage>170</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.matchemphys.2019.02.008</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Pires
de Abreu</surname><given-names>L. R.</given-names></name>; <name><surname>Ortiz</surname><given-names>R. M.</given-names></name>; <name><surname>de Castro</surname><given-names>S. C.</given-names></name>; <name><surname>Pedrazzoli</surname><given-names>J.</given-names><suffix>Jr.</suffix></name>
<article-title>HPLC determination of amoxicillin
comparative bioavailability in healthy volunteers after a single dose
administration</article-title>. <source>J. Pharm. Pharm. Sci.</source>
<year>2003</year>, <volume>6</volume> (<issue>2</issue>), <fpage>223</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">12935434</pub-id>
</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Souza</surname><given-names>J. G.
S.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Lima</surname><given-names>C. V.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>
<article-title>Proteomic
profile of the saliva and plasma protein layer adsorbed on Ti-Zr alloy:
the effect of sandblasted and acid-etched surface treatment</article-title>. <source>Biofouling</source>
<year>2020c</year>, <volume>36</volume> (<issue>4</issue>), <fpage>428</fpage>&#x02013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1080/08927014.2020.1769613</pub-id>.<pub-id pub-id-type="pmid">32456471</pub-id>
</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Hung</surname><given-names>C. C. U.</given-names></name>; <name><surname>Costa</surname><given-names>R. C.</given-names></name>; <name><surname>Pereira</surname><given-names>G.</given-names></name>; <name><surname>Abdo</surname><given-names>V. L.</given-names></name>; <name><surname>Noronha</surname><given-names>M. D. S.</given-names></name>; <name><surname>Retamal-Valdes</surname><given-names>B.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>
<article-title>Oral microbial colonization on titanium and polyetheretherketone
dental implant healing abutments: An in vitro and in vivo study</article-title>. <source>J. Prosthet Dent</source>
<year>2023</year>, <volume>S0022&#x02013;3913</volume> (<issue>23</issue>), <fpage>00538</fpage><pub-id pub-id-type="doi">10.1016/j.prosdent.2023.08.010</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>&#x000c1;lvarez</surname><given-names>S.</given-names></name>; <name><surname>Leiva-Sabadini</surname><given-names>C.</given-names></name>; <name><surname>Schuh</surname><given-names>C. M. A. P.</given-names></name>; <name><surname>Aguayo</surname><given-names>S.</given-names></name>
<article-title>Bacterial adhesion
to collagens: implications for biofilm formation and disease progression
in the oral cavity</article-title>. <source>Crit Rev. Microbiol</source>
<year>2022</year>, <volume>48</volume> (<issue>1</issue>), <fpage>83</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1080/1040841x.2021.1944054</pub-id>.<pub-id pub-id-type="pmid">34270375</pub-id>
</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Hoornaert</surname><given-names>A.</given-names></name>; <name><surname>d&#x02019;Arros</surname><given-names>C.</given-names></name>; <name><surname>Heymann</surname><given-names>M. F.</given-names></name>; <name><surname>Layrolle</surname><given-names>P.</given-names></name>
<article-title>Biocompatibility, resorption
and biofunctionality of a new synthetic biodegradable membrane for
guided bone regeneration</article-title>. <source>Biomed Mater.</source>
<year>2016</year>, <volume>11</volume> (<issue>4</issue>), <fpage>045012</fpage><pub-id pub-id-type="doi">10.1088/1748-6041/11/4/045012</pub-id>.<pub-id pub-id-type="pmid">27509180</pub-id>
</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Becker</surname><given-names>S. T.</given-names></name>; <name><surname>Terheyden</surname><given-names>H.</given-names></name>; <name><surname>Fabel</surname><given-names>M.</given-names></name>; <name><surname>Kandzia</surname><given-names>C.</given-names></name>; <name><surname>M&#x000f6;ller</surname><given-names>B.</given-names></name>; <name><surname>Wiltfang</surname><given-names>J.</given-names></name>
<article-title>Comparison of collagen membranes and polydioxanone
for reconstruction of the orbital floor after fractures</article-title>. <source>J. Craniofac Surg</source>
<year>2010</year>, <volume>21</volume> (<issue>4</issue>), <fpage>1066</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1097/SCS.0b013e3181e62c5f</pub-id>.<pub-id pub-id-type="pmid">20613556</pub-id>
</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Fontana</surname><given-names>A.</given-names></name>; <name><surname>Bistolfi</surname><given-names>A.</given-names></name>; <name><surname>Crova</surname><given-names>M.</given-names></name>; <name><surname>Massazza</surname><given-names>G.</given-names></name>
<article-title>Primary stability
of
a PGLA/Polydioxanone membrane for potential autologous chondrocyte
implantation in the hip joint. A cadaveric study</article-title>. <source>Hip Int.</source>
<year>2013</year>, <volume>23</volume> (<issue>3</issue>), <fpage>337</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.5301/hipint.5000023</pub-id>.<pub-id pub-id-type="pmid">23760749</pub-id>
</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Quirino</surname><given-names>L. C.</given-names></name>; <name><surname>de Azambuja Carvalho</surname><given-names>P. H.</given-names></name>; <name><surname>Neto</surname><given-names>R. T. A.</given-names></name>; <name><surname>Comachio</surname><given-names>C. A.</given-names></name>; <name><surname>Monteiro</surname><given-names>N. G.</given-names></name>; <name><surname>Ervolino-Silva</surname><given-names>A. C.</given-names></name>; <name><surname>Okamoto</surname><given-names>R.</given-names></name>; <name><surname>Pereira-Filho</surname><given-names>V. A.</given-names></name>
<article-title>Polydioxanone
Membrane Compared with Collagen Membrane for Bone Regeneration</article-title>. <source>Polymers</source>
<year>2023</year>, <volume>15</volume> (<issue>4</issue>), <fpage>868</fpage><pub-id pub-id-type="doi">10.3390/polym15040868.</pub-id>.<pub-id pub-id-type="pmid">36850154</pub-id>
</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Nair</surname><given-names>L. S.</given-names></name>; <name><surname>Laurencin</surname><given-names>C. T.</given-names></name>
<article-title>Biodegradable
polymers as biomaterials</article-title>. <source>Prog. Polym. Sci.</source>
<year>2007</year>, <volume>32</volume>, <fpage>762</fpage>&#x02013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1016/j.progpolymsci.2007.05.017</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Cintra
Moreira</surname><given-names>M. V.</given-names></name>; <name><surname>Figueiredo</surname><given-names>L. C.</given-names></name>; <name><surname>da Cunha Melo</surname><given-names>M. A. R.</given-names></name>; <name><surname>Uyeda</surname><given-names>F. H.</given-names></name>; <name><surname>da Silva</surname><given-names>L. D. A.</given-names></name>; <name><surname>Macedo</surname><given-names>T. T.</given-names></name>; <name><surname>Sacco</surname><given-names>R.</given-names></name>; <name><surname>Mour&#x000e3;o</surname><given-names>C. F.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Bueno-Silva</surname><given-names>B.</given-names></name>
<article-title>Evaluation
of the Microbial Profile on the Polydioxanone Membrane and the Collagen
Membrane Exposed to Multi-Species Subgingival Biofilm: An In Vitro
Study</article-title>. <source>Membranes</source>
<year>2023</year>, <volume>13</volume> (<issue>12</issue>), <fpage>907</fpage><pub-id pub-id-type="doi">10.3390/membranes13120907</pub-id>.<pub-id pub-id-type="pmid">38132911</pub-id>
</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Suzuki</surname><given-names>N.</given-names></name>; <name><surname>Yoneda</surname><given-names>M.</given-names></name>; <name><surname>Hirofuji</surname><given-names>T.</given-names></name>
<article-title>Mixed red-complex bacterial
infection
in periodontitis</article-title>. <source>Int. J. Dent</source>
<year>2013</year>, <volume>2013</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1155/2013/587279</pub-id>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Yu</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Lei</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Shu</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Tang</surname><given-names>X.</given-names></name>
<article-title>The Effects of Porphyromonas gingivalis
on Inflammatory and Immune Responses and Osteogenesis of Mesenchymal
Stem Cells</article-title>. <source>Stem Cells Dev.</source>
<year>2021</year>, <volume>30</volume> (<issue>24</issue>), <fpage>1191</fpage>&#x02013;<lpage>1201</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2021.0068</pub-id>.<pub-id pub-id-type="pmid">34628938</pub-id>
</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Lim</surname><given-names>G.</given-names></name>; <name><surname>Lin</surname><given-names>G. H.</given-names></name>; <name><surname>Monje</surname><given-names>A.</given-names></name>; <name><surname>Chan</surname><given-names>H. L.</given-names></name>; <name><surname>Wang</surname><given-names>H. L.</given-names></name>
<article-title>Wound Healing
Complications Following Guided Bone Regeneration for Ridge Augmentation:
A Systematic Review and Meta-Analysis</article-title>. <source>Int.
J. Oral Maxillofac Implants</source>
<year>2018</year>, <volume>33</volume> (<issue>1</issue>), <fpage>51</fpage><pub-id pub-id-type="doi">10.11607/jomi.5581</pub-id>.<pub-id pub-id-type="pmid">28817740</pub-id>
</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Takallu</surname><given-names>S.</given-names></name>; <name><surname>Mirzaei</surname><given-names>E.</given-names></name>; <name><surname>Zakeri Bazmandeh</surname><given-names>A.</given-names></name>; <name><surname>Ghaderi Jafarbeigloo</surname><given-names>H. R.</given-names></name>; <name><surname>Khorshidi</surname><given-names>H.</given-names></name>
<article-title>Addressing
Antimicrobial Properties in Guided Tissue/Bone
Regeneration Membrane: Enhancing Effectiveness in Periodontitis Treatment</article-title>. <source>ACS Infect Dis</source>
<year>2024</year>, <volume>10</volume> (<issue>3</issue>), <fpage>779</fpage>&#x02013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.3c00568</pub-id>.<pub-id pub-id-type="pmid">38300991</pub-id>
</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Adamuz-Jim&#x000e9;nez</surname><given-names>A.</given-names></name>; <name><surname>Manzano-Moreno</surname><given-names>F. J.</given-names></name>; <name><surname>Vallecillo</surname><given-names>C.</given-names></name>
<article-title>Regeneration Membranes Loaded with
Non-Antibiotic Anti-2 Microbials: A Review</article-title>. <source>Polymers</source>
<year>2023</year>, <volume>16</volume> (<issue>1</issue>), <fpage>95</fpage><pub-id pub-id-type="doi">10.3390/polym16010095</pub-id>.<pub-id pub-id-type="pmid">38201760</pub-id>
</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Teughels</surname><given-names>W.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Oud</surname><given-names>V.</given-names></name>; <name><surname>Mart&#x000ed;n</surname><given-names>C.</given-names></name>; <name><surname>Matesanz</surname><given-names>P.</given-names></name>; <name><surname>Herrera</surname><given-names>D.</given-names></name>
<article-title>Adjunctive effect of
systemic antimicrobials
in periodontitis therapy: A systematic review and meta-analysis</article-title>. <source>J. Clin Periodontol</source>
<year>2020</year>, <volume>47</volume> (<issue>S22</issue>), <fpage>257</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13264</pub-id>.</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Martins</surname><given-names>R.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Bar&#x000e3;o</surname><given-names>V. A. R.</given-names></name>; <name><surname>Shibli</surname><given-names>J. A.</given-names></name>
<article-title>Unraveling the effectiveness of antibiotics
for peri-implantitis treatment: A scoping review</article-title>. <source>Clin. Implant Dent. Relat. Res.</source>
<year>2023</year>, <volume>25</volume> (<issue>4</issue>), <fpage>767</fpage>&#x02013;<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1111/cid.13239</pub-id>.<pub-id pub-id-type="pmid">37386807</pub-id>
</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Demoion</surname><given-names>I. A.</given-names></name>; <name><surname>Persson</surname><given-names>G. R.</given-names></name>; <name><surname>Ammons</surname><given-names>W. F.</given-names></name>; <name><surname>Johnson</surname><given-names>R. H.</given-names></name>
<article-title>Effects of antibiotic
treatment on clinical conditions with guided tissue regeneration:
one-year results</article-title>. <source>J. Periodontol</source>
<year>1994</year>, <volume>65</volume> (<issue>7</issue>), <fpage>713</fpage>&#x02013;<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1902/jop.1994.65.7.713</pub-id>.<pub-id pub-id-type="pmid">7608850</pub-id>
</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Payer</surname><given-names>M.</given-names></name>; <name><surname>Tan</surname><given-names>W. C.</given-names></name>; <name><surname>Han</surname><given-names>J.</given-names></name>; <name><surname>Ivanovski</surname><given-names>S.</given-names></name>; <name><surname>Mattheos</surname><given-names>N.</given-names></name>; <name><surname>Pjetursson</surname><given-names>B. E.</given-names></name>; <name><surname>Zhuang</surname><given-names>L.</given-names></name>; <name><surname>Fokas</surname><given-names>G.</given-names></name>; <name><surname>Wong</surname><given-names>M. C. M.</given-names></name>; <name><surname>Acham</surname><given-names>S.</given-names></name>; <name><surname>Lang</surname><given-names>N. P.</given-names></name>; <article-title>The effect of systemic antibiotics
on clinical and patient-reported outcome measures of oral implant
therapy with simultaneous guided bone regeneration</article-title>. <source>Clin. Oral Implants Res.</source>
<year>2020</year>, <volume>31</volume> (<issue>5</issue>), <fpage>442</fpage>&#x02013;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1111/clr.13580</pub-id>.<pub-id pub-id-type="pmid">31957070</pub-id>
</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Soares</surname><given-names>G. M.</given-names></name>; <name><surname>Teles</surname><given-names>F.</given-names></name>; <name><surname>Starr</surname><given-names>J. R.</given-names></name>; <name><surname>Feres</surname><given-names>M.</given-names></name>; <name><surname>Patel</surname><given-names>M.</given-names></name>; <name><surname>Martin</surname><given-names>L.</given-names></name>; <name><surname>Teles</surname><given-names>R.</given-names></name>
<article-title>Effects of azithromycin, metronidazole,
amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial
subgingival biofilm model</article-title>. <source>Antimicrob. Agents
Chemother.</source>
<year>2015</year>, <volume>59</volume> (<issue>5</issue>), <fpage>2791</fpage>&#x02013;<lpage>2798</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.04974-14</pub-id>.<pub-id pub-id-type="pmid">25733510</pub-id>
</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Lekang</surname><given-names>K.</given-names></name>; <name><surname>Shekhar</surname><given-names>S.</given-names></name>; <name><surname>Berild</surname><given-names>D.</given-names></name>; <name><surname>Petersen</surname><given-names>F. C.</given-names></name>; <name><surname>Winther-Larsen</surname><given-names>H. C.</given-names></name>
<article-title>Effects
of different amoxicillin treatment durations on microbiome diversity
and composition in the gut</article-title>. <source>PLoS One</source>
<year>2022</year>, <volume>17</volume> (<issue>10</issue>), <elocation-id>e0275737</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0275737</pub-id>.<pub-id pub-id-type="pmid">36301847</pub-id>
</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Tenenbaum</surname><given-names>H.</given-names></name>; <name><surname>Jehl</surname><given-names>F.</given-names></name>; <name><surname>Gallion</surname><given-names>C.</given-names></name>; <name><surname>Dahan</surname><given-names>M.</given-names></name>
<article-title>Amoxicillin and clavulanic
acid concentrations in gingival crevicular fluid</article-title>. <source>J. Clin Periodontol</source>
<year>1997</year>, <volume>24</volume> (<issue>11</issue>), <fpage>804</fpage>&#x02013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051x.1997.tb01193.x</pub-id>.<pub-id pub-id-type="pmid">9402501</pub-id>
</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Duewelhenke</surname><given-names>N.</given-names></name>; <name><surname>Krut</surname><given-names>O.</given-names></name>; <name><surname>Eysel</surname><given-names>P.</given-names></name>
<article-title>Influence
on mitochondria and cytotoxicity
of different antibiotics administered in high concentrations on primary
human osteoblasts and cell lines</article-title>. <source>Antimicrob.
Agents Chemother.</source>
<year>2007</year>, <volume>51</volume> (<issue>1</issue>), <fpage>54</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00729-05</pub-id>.<pub-id pub-id-type="pmid">17088489</pub-id>
</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Rabe</surname><given-names>M.</given-names></name>; <name><surname>Verdes</surname><given-names>D.</given-names></name>; <name><surname>Seeger</surname><given-names>S.</given-names></name>
<article-title>Understanding protein adsorption
phenomena at solid surfaces</article-title>. <source>Adv. Colloid Interface
Sci.</source>
<year>2011</year>, <volume>162</volume>, <fpage>87</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.cis.2010.12.007</pub-id>.<pub-id pub-id-type="pmid">21295764</pub-id>
</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Kawai</surname><given-names>H.</given-names></name>; <name><surname>Shibata</surname><given-names>Y.</given-names></name>; <name><surname>Miyazaki</surname><given-names>T.</given-names></name>
<article-title>Glow discharge
plasma pretreatment
enhances osteoclast differentiation and survival on titanium plates</article-title>. <source>Biomaterials</source>
<year>2004</year>, <volume>25</volume> (<issue>10</issue>), <fpage>1805</fpage>&#x02013;<lpage>1811</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2003.08.032</pub-id>.<pub-id pub-id-type="pmid">14738844</pub-id>
</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Goonoo</surname><given-names>N.</given-names></name>; <name><surname>Jeetah</surname><given-names>R.</given-names></name>; <name><surname>Bhaw-Luximon</surname><given-names>A.</given-names></name>; <name><surname>Jhurry</surname><given-names>D.</given-names></name>
<article-title>Polydioxanone-based
bio-materials for tissue engineering and drug/gene delivery applications</article-title>. <source>Eur. J. Pharm. Biopharm.</source>
<year>2015</year>, <volume>97</volume>, <fpage>371</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2015.05.024</pub-id>.<pub-id pub-id-type="pmid">26614558</pub-id>
</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Malhotra-Kumar</surname><given-names>S.</given-names></name>; <name><surname>Van Heirstraeten</surname><given-names>L.</given-names></name>; <name><surname>Coenen</surname><given-names>S.</given-names></name>; <name><surname>Lammens</surname><given-names>C.</given-names></name>; <name><surname>Adriaenssens</surname><given-names>N.</given-names></name>; <name><surname>Kowalczyk</surname><given-names>A.</given-names></name>; <name><surname>Godycki-Cwirko</surname><given-names>M.</given-names></name>; <name><surname>Bielicka</surname><given-names>Z.</given-names></name>; <name><surname>Hupkova</surname><given-names>H.</given-names></name>; <name><surname>Lannering</surname><given-names>C.</given-names></name>; <name><surname>M&#x000f6;lstad</surname><given-names>S.</given-names></name>; <name><surname>Fernandez-Vandellos</surname><given-names>P.</given-names></name>; <name><surname>Torres</surname><given-names>A.</given-names></name>; <name><surname>Parizel</surname><given-names>M.</given-names></name>; <name><surname>Ieven</surname><given-names>M.</given-names></name>; <name><surname>Butler</surname><given-names>C. C.</given-names></name>; <name><surname>Verheij</surname><given-names>T.</given-names></name>; <name><surname>Little</surname><given-names>P.</given-names></name>; <name><surname>Goossens</surname><given-names>H.</given-names></name>; <article-title>Impact of amoxicillin
therapy on resistance selection in patients with community-acquired
lower respiratory tract infections: a randomized, placebo-controlled
study</article-title>. <source>J. Antimicrob. Chemother.</source>
<year>2016</year>, <volume>71</volume> (<issue>11</issue>), <fpage>3258</fpage>&#x02013;<lpage>3267</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkw234</pub-id>.<pub-id pub-id-type="pmid">27353466</pub-id>
</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Thurnheer</surname><given-names>T.</given-names></name>; <name><surname>Bensland</surname><given-names>S.</given-names></name>; <name><surname>Eick</surname><given-names>S.</given-names></name>; <name><surname>Kulik</surname><given-names>E. M.</given-names></name>; <name><surname>Attin</surname><given-names>T.</given-names></name>; <name><surname>Karygianni</surname><given-names>L.</given-names></name>
<article-title>AntibioticResistance
among Fusobacterium, Capnocytophaga,
and Leptotrichia Species of the Oral Cavity</article-title>. <source>Oral Health Prev Dent</source>
<year>2023</year>, <volume>21</volume>, <fpage>93</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.3290/j.ohpd.b4009553</pub-id>.<pub-id pub-id-type="pmid">37014213</pub-id>
</mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Kulik
Kunz</surname><given-names>E. M.</given-names></name>; <name><surname>Lenkeit</surname><given-names>K.</given-names></name>; <name><surname>Waltimo</surname><given-names>T.</given-names></name>; <name><surname>Weiger</surname><given-names>R.</given-names></name>; <name><surname>Walter</surname><given-names>C.</given-names></name>
<article-title>Combinatorial effects of amoxicillin and metronidazole
on selected periodontal bacteria and whole plaque samples</article-title>. <source>Arch. Oral Biol.</source>
<year>2014</year>, <volume>59</volume> (<issue>6</issue>), <fpage>608</fpage>&#x02013;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2014.03.007</pub-id>.<pub-id pub-id-type="pmid">24727003</pub-id>
</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Zhang</surname><given-names>S.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Lalsiamthara</surname><given-names>J.</given-names></name>; <name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Qi</surname><given-names>L.</given-names></name>; <name><surname>Deng</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>
<article-title>Current research
progress on Prevotella
intermedia and associated diseases</article-title>. <source>Crit Rev.
Microbiol</source>
<year>2024</year>, <volume>14</volume>, <fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/1040841X.2024.2390594</pub-id>.</mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Ghensi</surname><given-names>P.</given-names></name>; <name><surname>Manghi</surname><given-names>P.</given-names></name>; <name><surname>Zolfo</surname><given-names>M.</given-names></name>; <name><surname>Armanini</surname><given-names>F.</given-names></name>; <name><surname>Pasolli</surname><given-names>E.</given-names></name>; <name><surname>Bolzan</surname><given-names>M.</given-names></name>; <name><surname>Bertelle</surname><given-names>A.</given-names></name>; <name><surname>Dell&#x02019;Acqua</surname><given-names>F.</given-names></name>; <name><surname>Dellasega</surname><given-names>E.</given-names></name>; <name><surname>Waldner</surname><given-names>R.</given-names></name>; <name><surname>Tessarolo</surname><given-names>F.</given-names></name>; <name><surname>Tomasi</surname><given-names>C.</given-names></name>; <name><surname>Segata</surname><given-names>N.</given-names></name>
<article-title>Strong oral plaque microbiome signatures
for dental implant diseases identified by strain-resolution metagenomics</article-title>. <source>NPJ. Biofilms Microbiomes</source>
<year>2020</year>, <volume>6</volume> (<issue>1</issue>), <fpage>47</fpage><pub-id pub-id-type="doi">10.1038/s41522-020-00155-7</pub-id>.<pub-id pub-id-type="pmid">33127901</pub-id>
</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="book" id="cit67"><person-group person-group-type="allauthors"><name><surname>Akhavan</surname><given-names>B. J.</given-names></name>, <name><surname>Khanna</surname><given-names>N. R.</given-names></name>, <name><surname>Vijhani</surname><given-names>P.</given-names></name></person-group>. <source>Amoxicillin</source>; <publisher-name>StatPearls Publishing</publisher-name>: <publisher-loc>Treasure Island (FL)</publisher-loc>, <year>2024</year>.</mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Shibli</surname><given-names>J. A.</given-names></name>; <name><surname>Nagay</surname><given-names>B. E.</given-names></name>; <name><surname>Suarez</surname><given-names>L. J.</given-names></name>; <name><surname>Urdaniga
Hung</surname><given-names>C.</given-names></name>; <name><surname>Bertolini</surname><given-names>M.</given-names></name>; <name><surname>Barao</surname><given-names>V. A. R.</given-names></name>; <name><surname>Souza</surname><given-names>J. G. S.</given-names></name>
<article-title>Bone Tissue Engineering
Using Osteogenic Cells: From the Bench to the Clinical Application</article-title>. <source>Tissue Eng. Part C Methods</source>
<year>2022</year>, <volume>28</volume> (<issue>5</issue>), <fpage>179</fpage>&#x02013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2022.0021</pub-id>.<pub-id pub-id-type="pmid">35166162</pub-id>
</mixed-citation></ref></ref-list></back></article>